MX9304619A - Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion. - Google Patents

Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion.

Info

Publication number
MX9304619A
MX9304619A MX9304619A MX9304619A MX9304619A MX 9304619 A MX9304619 A MX 9304619A MX 9304619 A MX9304619 A MX 9304619A MX 9304619 A MX9304619 A MX 9304619A MX 9304619 A MX9304619 A MX 9304619A
Authority
MX
Mexico
Prior art keywords
interleukin
dimerica
nerves
preparation
enzyme derived
Prior art date
Application number
MX9304619A
Other languages
English (en)
Inventor
Michal Schwartz
Shoshana Eitan
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL10268692A external-priority patent/IL102686A/en
Priority claimed from IL103469A external-priority patent/IL103469A0/xx
Priority claimed from IL105752A external-priority patent/IL105752A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of MX9304619A publication Critical patent/MX9304619A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención provee nuevas enzimas transglutaminasa derivada de nervios que convierte la interleucina-2 inmunoderivada a interleucina-2 dimérica que tenga una actividad citotóxica de oligodendrocitos. Una enzima de transglutinasa derivada de nervios caracterizada porque es obtenible del nervio óptico lesionado del pez que convierte la interleucina-2 (IL-2) a IL-2 dimérica que tiene actividad citotóxica para los oligondendrocitos.
MX9304619A 1992-07-30 1993-07-30 Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion. MX9304619A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL10268692A IL102686A (en) 1992-07-30 1992-07-30 Nerve-derived transglutaminase and pharmaceutical composition comprising it
IL103469A IL103469A0 (en) 1992-10-20 1992-10-20 Preparation of dimeric il-2 having oligodendrocyte cytotoxic activity and enzyme therefor
IL105752A IL105752A0 (en) 1993-05-19 1993-05-19 Preparation of dimeric il-2 having oligodendrocyte cytotoxic activity and enzyme therefor

Publications (1)

Publication Number Publication Date
MX9304619A true MX9304619A (es) 1994-05-31

Family

ID=27271570

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304619A MX9304619A (es) 1992-07-30 1993-07-30 Interleucina-2 dimerica producida enzimaticamente y una enzima de transglutaminasa derivada de los nervios para su preparacion.

Country Status (11)

Country Link
EP (1) EP0610475B1 (es)
JP (1) JP3310289B2 (es)
CN (1) CN1084888A (es)
AT (1) ATE214730T1 (es)
AU (1) AU667572B2 (es)
CA (1) CA2119873A1 (es)
DE (1) DE69331730T2 (es)
FI (1) FI941451A7 (es)
HU (1) HU218852B (es)
MX (1) MX9304619A (es)
WO (1) WO1994003059A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0851029A4 (en) * 1995-06-08 2001-05-23 Ajinomoto Kk MICROBIAL PROCESS FOR THE PRODUCTION OF TRANSGLUTAMINASE
IL125983A0 (en) * 1998-08-30 1999-04-11 Yeda Res & Dev Pharmaceutical composition comprising factor xiiia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97365A0 (en) * 1991-02-27 1992-05-25 Yeda Res & Dev Pharmaceutical compositions comprising a lymphokine
IL91459A0 (en) * 1989-08-28 1990-04-29 Yeda Res & Dev Oligodendrocyte inhibitory factor

Also Published As

Publication number Publication date
JPH06511393A (ja) 1994-12-22
EP0610475A1 (en) 1994-08-17
DE69331730T2 (de) 2002-10-31
HU218852B (hu) 2000-12-28
AU667572B2 (en) 1996-03-28
FI941451L (fi) 1994-05-11
HUT70302A (en) 1995-09-28
ATE214730T1 (de) 2002-04-15
AU4795093A (en) 1994-03-03
WO1994003059A1 (en) 1994-02-17
FI941451A0 (fi) 1994-03-29
DE69331730D1 (de) 2002-04-25
FI941451A7 (fi) 1994-05-11
EP0610475A4 (en) 1997-04-23
HU9400900D0 (en) 1994-06-28
EP0610475B1 (en) 2002-03-20
JP3310289B2 (ja) 2002-08-05
CN1084888A (zh) 1994-04-06
CA2119873A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
ES2052565T3 (es) Un procedimiento para licuar una suspension de almidon o granos amilaceos.
BR9510604A (pt) Aperfeiçoamento do rendimento de plantas
HU9403343D0 (en) New pharmaceutical uses of krill enzymes
ES2043626T3 (es) Procedimiento para obtener un preparado farmaceutico.
DE69133602D1 (de) Pflanzliche Thioesterasen
PA8443001A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
AU2769995A (en) Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme
DE69331147D1 (de) Verbindungsimplantat
PT721343E (pt) Formulacoes farmaceuticas de factor de crescimento do tecido nervoso
IL104716A0 (en) Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace
ATE239083T1 (de) Arabinoxylan abbauende enzymen
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
ES2036522T3 (es) Un procedimiento para la preparacion de un nuevo derivado ester de pirrolidinil amida.
BR9510602A (pt) Aperfeiçoamento do rendimento de plantas
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
ES2130527T3 (es) Procedimiento de hidrolisis enzimatica para la conversion de taxanos con azucar en c-7 en taxanos con hidroxilo en c-7.
DE69333185D1 (de) Für chitin-deacetylase kodierende dna
ES2044561T3 (es) Composiciones liquidas administrables por via oral a base de aceites comestibles.
ES2053623T3 (es) Procedimiento para la preparacion de enzimas fijadas a un soporte.
AU7241281A (en) Compounds of mucolytic activity
ES2123669T3 (es) Derivados del plasminogeno que se activan con trombina.
FI941451A0 (fi) Entsymaattisesti valmistettu dimeerinen IL-2 ja sen valmistuksessa käytettävä, hermoista johdettu transglutaminaasi
ES2026485T3 (es) Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas.
IT1250017B (it) Enzima immobilizzato, relativo procedimento di preparazione ed impiego
FI870890A0 (fi) Antiglaucomafoereningar.